SB144 Alabama 2022 Session

Summary

Primary Sponsor

Tim MelsonSenator

Republican

Session

Regular Session 2022

Title

Controlled substances, to exempt non-psychoactive cannabinols derived from hemp from the controlled substance list, Sec. 20-2-23 am'd.

Summary

The bill narrows the hemp-derived exemption from Schedule I to only non-psychoactive cannabinoids, excluding psychoactive hemp cannabinoids like delta-8 THC.

What This Bill Does

If enacted, it amends Section 20-2-23 to limit the Schedule I exemption to non-psychoactive cannabinoids derived from or found in hemp. This means psychoactive hemp cannabinoids, such as delta-8 THC, would no longer be exempt and would be treated as Schedule I substances. Non-psychoactive hemp cannabinoids would remain exempt, while psychoactive hemp cannabinoids would become controlled. The overall structure for other listed substances under Schedule I would continue under the bill.

Who It Affects

• Hemp product manufacturers and retailers: if their products contain psychoactive hemp cannabinoids (e.g., delta-8), those products would no longer be exempt and would be subject to Schedule I controls.
• Consumers of hemp-derived cannabinoids: psychoactive hemp products could become illegal or more tightly regulated, while non-psychoactive hemp products would remain exempt.

Key Provisions

• Amends Section 20-2-23 to restrict the hemp-derived exemption from Schedule I to non-psychoactive cannabinols derived from or found in hemp.
• Declares that delta-8 THC is psychoactive and would not be exempt, making psychoactive hemp cannabinoids subject to Schedule I.

AI-generated summary using openai/gpt-5-nano on Feb 22, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Controlled Substances